Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 56

1.

Glucagon-like-peptide-1 receptor expression in normal and diseased human thyroid and pancreas.

Waser B, Blank A, Karamitopoulou E, Perren A, Reubi JC.

Mod Pathol. 2014 Sep 12. doi: 10.1038/modpathol.2014.113. [Epub ahead of print]

PMID:
25216224
[PubMed - as supplied by publisher]
2.

Assessment of Tumor Regression of Esophageal Adenocarcinomas After Neoadjuvant Chemotherapy: Comparison of 2 Commonly Used Scoring Approaches.

Karamitopoulou E, Thies S, Zlobec I, Ott K, Feith M, Slotta-Huspenina J, Lordick F, Becker K, Langer R.

Am J Surg Pathol. 2014 Aug 19. [Epub ahead of print]

PMID:
25140894
[PubMed - as supplied by publisher]
3.

Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19 as a favorable prognostic factor in colorectal cancer: a retrospective multicenter study of 675 patients.

Helbling M, Lukesch A, Haimovici A, Karamitopoulou E, Berger MD, Hädrich M, Mallaev M, Schnüriger B, Koelzer VH, Dawson H, Borner M, Langer R, Rosenberg R, Nitsche U, Inderbitzin D, Lugli A, Tschan M, Zlobec I.

Oncotarget. 2014 Jul 15;5(13):4671-82.

PMID:
25015728
[PubMed - in process]
Free PMC Article
4.

Increased number of non-degranulated mast cells in pancreatic ductal adenocarcinoma but not in acute pancreatitis.

Karamitopoulou E, Shoni M, Theoharides TC.

Int J Immunopathol Pharmacol. 2014 Apr-Jun;27(2):213-20.

PMID:
25004833
[PubMed - indexed for MEDLINE]
5.

HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker.

Sconocchia G, Eppenberger-Castori S, Zlobec I, Karamitopoulou E, Arriga R, Coppola A, Caratelli S, Spagnoli GC, Lauro D, Lugli A, Han J, Iezzi G, Ferrone C, Ferlosio A, Tornillo L, Droeser R, Rossi P, Attanasio A, Ferrone S, Terracciano L.

Neoplasia. 2014 Jan;16(1):31-42.

PMID:
24563618
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC).

Karamitopoulou E, Zlobec I, Gloor B, Kondi-Pafiti A, Lugli A, Perren A.

J Transl Med. 2013 Dec 14;11:311. doi: 10.1186/1479-5876-11-311.

PMID:
24330423
[PubMed - in process]
Free PMC Article
7.

Pretreatment with sevoflurane attenuates direct lung injury.

Kalimeris K, Zerva A, Matsota P, Nomikos T, Fragopoulou E, Politi AN, Karamitopoulou E, Kostopanagiotou G.

Minerva Anestesiol. 2014 Jun;80(6):635-44. Epub 2013 Dec 4.

PMID:
24299917
[PubMed - in process]
8.

Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer.

Baker K, Rath T, Flak MB, Arthur JC, Chen Z, Glickman JN, Zlobec I, Karamitopoulou E, Stachler MD, Odze RD, Lencer WI, Jobin C, Blumberg RS.

Immunity. 2013 Dec 12;39(6):1095-107. doi: 10.1016/j.immuni.2013.11.003. Epub 2013 Nov 27.

PMID:
24290911
[PubMed - indexed for MEDLINE]
9.

Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.

Dawson H, Galván JA, Helbling M, Muller DE, Karamitopoulou E, Koelzer VH, Economou M, Hammer C, Lugli A, Zlobec I.

Int J Cancer. 2014 May 15;134(10):2342-51. doi: 10.1002/ijc.28564. Epub 2013 Nov 13.

PMID:
24166180
[PubMed - indexed for MEDLINE]
10.

The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcome.

Dawson H, Koelzer VH, Karamitopoulou E, Economou M, Hammer C, Muller DE, Lugli A, Zlobec I.

Histopathology. 2014 Mar;64(4):577-84. doi: 10.1111/his.12294. Epub 2013 Dec 28.

PMID:
24111856
[PubMed - in process]
11.

Role of epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma: is tumor budding the missing link?

Karamitopoulou E.

Front Oncol. 2013 Sep 17;3:221. doi: 10.3389/fonc.2013.00221. Review.

PMID:
24062980
[PubMed]
Free PMC Article
12.

The growing galectin network in colon cancer and clinical relevance of cytoplasmic galectin-3 reactivity.

Dawson H, André S, Karamitopoulou E, Zlobec I, Gabius HJ.

Anticancer Res. 2013 Aug;33(8):3053-9.

PMID:
23898060
[PubMed - indexed for MEDLINE]
13.

Tumour budding is a strong and independent prognostic factor in pancreatic cancer. Reply to comment.

Karamitopoulou E, Gloor B.

Eur J Cancer. 2013 Jul;49(10):2458-9. doi: 10.1016/j.ejca.2013.03.028. Epub 2013 May 7. No abstract available.

PMID:
23664012
[PubMed - indexed for MEDLINE]
14.

Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer.

Koelzer VH, Karamitopoulou E, Dawson H, Kondi-Pafiti A, Zlobec I, Lugli A.

Br J Cancer. 2013 May 28;108(10):2088-96. doi: 10.1038/bjc.2013.197. Epub 2013 Apr 30.

PMID:
23632477
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Tumor budding cells, cancer stem cells and epithelial-mesenchymal transition-type cells in pancreatic cancer.

Karamitopoulou E.

Front Oncol. 2013 Jan 4;2:209. doi: 10.3389/fonc.2012.00209. eCollection 2012.

PMID:
23316479
[PubMed]
Free PMC Article
16.

Tumour budding is a strong and independent prognostic factor in pancreatic cancer.

Karamitopoulou E, Zlobec I, Born D, Kondi-Pafiti A, Lykoudis P, Mellou A, Gennatas K, Gloor B, Lugli A.

Eur J Cancer. 2013 Mar;49(5):1032-9. doi: 10.1016/j.ejca.2012.10.022. Epub 2012 Nov 21.

PMID:
23177090
[PubMed - indexed for MEDLINE]
17.

Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer.

Horcic M, Koelzer VH, Karamitopoulou E, Terracciano L, Puppa G, Zlobec I, Lugli A.

Hum Pathol. 2013 May;44(5):697-705. doi: 10.1016/j.humpath.2012.07.026. Epub 2012 Nov 15.

PMID:
23159156
[PubMed - indexed for MEDLINE]
18.

Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer.

Karamitopoulou E, Zlobec I, Kölzer V, Kondi-Pafiti A, Patsouris ES, Gennatas K, Lugli A.

Mod Pathol. 2013 Feb;26(2):295-301. doi: 10.1038/modpathol.2012.155. Epub 2012 Sep 28.

PMID:
23018875
[PubMed - indexed for MEDLINE]
Free Article
19.

Tumour budding: a promising parameter in colorectal cancer.

Lugli A, Karamitopoulou E, Zlobec I.

Br J Cancer. 2012 May 22;106(11):1713-7. doi: 10.1038/bjc.2012.127. Epub 2012 Apr 24. Review.

PMID:
22531633
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma.

Piscuoglio S, Zlobec I, Pallante P, Sepe R, Esposito F, Zimmermann A, Diamantis I, Terracciano L, Fusco A, Karamitopoulou E.

Histopathology. 2012 Feb;60(3):397-404. doi: 10.1111/j.1365-2559.2011.04121.x.

PMID:
22276603
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk